Cargando…

Disparities in Reported Testing for 1p/19q Codeletion in Oligodendroglioma and Oligoastrocytoma Patients: An Analysis of the National Cancer Database

PURPOSE: A chromosomal 1p/19q codeletion was included as a required diagnostic component of oligodendrogliomas in the 2016 World Health Organization (WHO) classification of central nervous system tumors. We sought to evaluate disparities in reported testing for 1p/19q codeletion among oligodendrogli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zreik, Jad, Kerezoudis, Panagiotis, Alvi, Mohammed Ali, Yolcu, Yagiz U., Kizilbash, Sani H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630738/ https://www.ncbi.nlm.nih.gov/pubmed/34858822 http://dx.doi.org/10.3389/fonc.2021.746844

Ejemplares similares

Survival and associated predictors for patients with pineoblastoma or pineal parenchymal tumors of intermediate differentiation older than 3 years: Insights from the National Cancer Database
por: Kerezoudis, Panagiotis, et al.
Publicado: (2022)

Case report: Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, associated with a germline mutation in PMS2
por: Merchant, Mythili, et al.
Publicado: (2022)

Primary Leptomeningeal Oligodendroglioma, IDH-Mutant, 1p/19q-Codeleted
por: Ballester, Leomar Y., et al.
Publicado: (2018)

Id4 and FABP7 are preferentially expressed in cells with astrocytic features in oligodendrogliomas and oligoastrocytomas
por: Liang, Yu, et al.
Publicado: (2005)

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile
por: Ducray, François, et al.
Publicado: (2008)

Case report: Spinal drop metastasis of IDH-mutant, 1p/19q-codeleted oligodendroglioma
por: Karaman, Ahmet Kursat, et al.
Publicado: (2022)

Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma
por: Ma, Sirui, et al.
Publicado: (2021)

Treating oligodendroglioma – An analysis of a homogeneous 1p/19q-codeleted and isocitrate dehydrogenase-mutant patient cohort
por: Allwohn, Luisa, et al.
Publicado: (2023)

CeRNA Network Analysis Representing Characteristics of Different Tumor Environments Based on 1p/19q Codeletion in Oligodendrogliomas
por: Ahn, Ju Won, et al.
Publicado: (2020)

Extracranial metastasis of anaplastic oligoastrocytoma
por: Kang, Zhuang, et al.
Publicado: (2018)

Bone metastases from a 1p/19q codeleted and IDH1-mutant anaplastic oligodendroglioma: a case report
por: Burgy, Mickaël, et al.
Publicado: (2019)

A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas
por: Gilhodes, Julia, et al.
Publicado: (2023)

Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta‐analysis based on a Cochrane systematic review
por: Brandner, Sebastian, et al.
Publicado: (2022)

Malignant oligoastrocytoma in the spinal cord of a cat
por: HASEGAWA, Dai, et al.
Publicado: (2022)

Oligodendrogliomas, IDH-mutant and 1p/19q-codeleted, arising during teenage years often lack TERT promoter mutation that is typical of their adult counterparts
por: Lee, Julieann, et al.
Publicado: (2018)

Time-to-enrollment in clinical trials investigating neurological recovery in chronic spinal cord injury: observations from a systematic review and ClinicalTrials.gov database
por: Moinuddin, F M, et al.
Publicado: (2021)

True anaplastic oligoastrocytoma with dual genotype: illustrative case
por: Mizuno, Reina, et al.
Publicado: (2022)

Multiple metastases to the bone and bone marrow from a 1p/19q-codeleted and IDH2-mutant anaplastic oligodendroglioma: a case report and literature review
por: Shimizu, Hiroyuki, et al.
Publicado: (2020)

Ability of Radiomics in Differentiation of Anaplastic Oligodendroglioma From Atypical Low-Grade Oligodendroglioma Using Machine-Learning Approach
por: Zhang, Yang, et al.
Publicado: (2019)

Sociodemographic Disparities in the Diagnosis and Prognosis of Patients With Cervical Cancer: An Analysis of the Surveillance, Epidemiology, and End Results Program
por: Zreik, Jad, et al.
Publicado: (2023)

Current and Future Frontiers of Molecularly Defined Oligodendrogliomas
por: Rincon-Torroella, Jordina, et al.
Publicado: (2022)

Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic
por: Li, Yan-Xi, et al.
Publicado: (2016)

Correction: Ahn, J.W., et al. CeRNA Network Analysis Representing Characteristics of Different Tumor Environments Based on 1p/19q Codeletion in Oligodendrogliomas. Cancers 2020, 12, 2543
por: Ahn, Ju Won, et al.
Publicado: (2021)

A dual-genotype oligoastrocytoma with histologic, molecular, radiological and time-course features
por: Nasrallah, Mac Lean P., et al.
Publicado: (2020)

Recurrent Glioma With Lineage Conversion From Oligodendroglioma to Astrocytoma in Two Cases
por: Kim, Jo-Heon, et al.
Publicado: (2019)

1p/19q codeletion and RET rearrangements in small-cell lung cancer
por: Lu, Hongyang, et al.
Publicado: (2016)

How I treat anaplastic glioma without 1p/19q codeletion
por: Berghoff, Anna, et al.
Publicado: (2019)

Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma
por: Lv, Lei, et al.
Publicado: (2021)

Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study
por: Habiba, Umma, et al.
Publicado: (2021)

Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy
por: Yu, Guangyang, et al.
Publicado: (2021)

Vasculogenic Mimicry Formation Predicts Tumor Progression in Oligodendroglioma
por: Xie, Jing, et al.
Publicado: (2021)

Recurrent oligodendroglioma with changed 1p/19q status
por: Barresi, Valeria, et al.
Publicado: (2022)

Common Molecular Alterations in Canine Oligodendroglioma and Human Malignant Gliomas and Potential Novel Therapeutic Targets
por: Mitchell, Dana, et al.
Publicado: (2019)

Radiomics-Based Machine Learning Technology Enables Better Differentiation Between Glioblastoma and Anaplastic Oligodendroglioma
por: Fan, Yimeng, et al.
Publicado: (2019)

Case report: ISL2 is involved in malignant transformation in a patient with multiple relapsed oligodendroglioma
por: Chen, Shu-Na, et al.
Publicado: (2022)

IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas
por: Leeper, Heather E., et al.
Publicado: (2015)

Frequency of false-positive FISH 1p/19q codeletion in adult diffuse astrocytic gliomas
por: Ball, Matthew K, et al.
Publicado: (2020)

Oligodendroglioma in childhood.
por: Wang, K. C., et al.
Publicado: (1993)

Imaging of oligodendroglioma
por: Smits, Marion
Publicado: (2016)

Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study
por: Garnier, Louis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iafs9vcpn4pa9o15eu8i166ndc